Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...

The latest car news, videos and expert reviews, from Cars.com's independent automotive journalists A low purchase price is only the start to finding a truly affordable car. Their spectacular fuel ...

Feb. 23Trump’s approval rating dropped to 36% in the latest CNN/SSRS poll, from 48% a year ago (the poll of 2,496 U.S. adults conducted Feb. 17-20 has a margin of ...